KPMA to look into drug makers

Published: 2009-10-13 07:00:00

Updated: 2009-10-13 07:00:00

The Korea Pharmaceutical Manufacturers Association (KPMA), a local pharmaceutical business lobby group, has embarked on looking into eight drug makers’ undue business practices such as rebate-offering, according to a KPMA official.

The association said on October 8 that the KPMA plans to uncov...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK